Search: onr:"swepub:oai:DiVA.org:oru-49608" >
2015 European guide...
2015 European guideline on the management of Chlamydia trachomatis infections
-
- Lanjouw, E. (author)
- Department of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands
-
- Ouburg, S. (author)
- Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands
-
- de Vries, H. J. (author)
- Department of Dermatology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands; STI Outpatient Clinic, Infectious Disease Cluster, Health Service Amsterdam, Amsterdam, The Netherlands; Center for Infection and Immunology Amsterdam (CINIMA), Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands
-
show more...
-
- Stary, A. (author)
- Outpatients’ Centre for Infectious Venereodermatological Diseases, Vienna, Austria
-
- Radcliffe, K. (author)
- University Hospital Birmingham Foundation NHS Trust, Birmingham, United Kingdom
-
- Unemo, Magnus, 1970- (author)
- Örebro universitet,Institutionen för hälsovetenskaper,WHO Collaborating Center for Gonorrhoea and other Sexually Transmitted Infections, National Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
-
show less...
-
(creator_code:org_t)
- 2015-11-24
- 2016
- English.
-
In: International Journal of STD and AIDS (London). - London, United Kingdom : Sage Publications. - 0956-4624 .- 1758-1052. ; 27:5, s. 333-348
- Related links:
-
https://urn.kb.se/re...
-
show more...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Chlamydia trachomatis infections, which most frequently are asymptomatic, are major public health concerns globally. The 2015 European C. trachomatis guideline provides: up-to-date guidance regarding broader indications for testing and treatment of C. trachomatis infections; a clearer recommendation of using exclusively-validated nucleic acid amplification tests for diagnosis; advice on (repeated) C. trachomatis testing; the recommendation of increased testing to reduce the incidence of pelvic inflammatory disease and prevent exposure to infection; and recommendations to identify, verify and report C. trachomatis variants. Improvement of access to testing, test performance, diagnostics, antimicrobial treatment and follow-up of C. trachomatis patients are crucial to control its spread. For detailed background, evidence base and discussions, see the background review for the present 2015 European guideline on the management of Chlamydia trachomatis infections (Lanjouw E, etal. Int J STD AIDS. 2015).
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Immunologi inom det medicinska området (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Immunology in the medical area (hsv//eng)
Keyword
- Chlamydia trachomatis
- genital
- sexually transmitted infection
- lymphogranuloma venereum
- pelvic inflammatory disease
- Europe
- diagnosis
- treatment
- antibiotic
- Immunologi
- Immunology
- Infektionssjukdomar
- Infectious Diseases
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database